Suppr超能文献

白内障手术矫正视力损害和提高老年人生存率:蓝山眼研究队列。

Correction of visual impairment by cataract surgery and improved survival in older persons: the Blue Mountains Eye Study cohort.

机构信息

Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, Australia.

出版信息

Ophthalmology. 2013 Sep;120(9):1720-7. doi: 10.1016/j.ophtha.2013.02.009. Epub 2013 May 9.

Abstract

OBJECTIVE

We assessed whether correction of visual impairment (VI) by cataract surgery was associated with improved long-term survival in an older Australian population.

DESIGN

Population-based cohort study.

PARTICIPANTS

In the Blue Mountains Eye Study, 354 participants, aged ≥ 49 years, had both cataract and VI or had undergone cataract surgery before baseline examinations. They were subsequently examined after 5- and 10-year follow-ups.

METHODS

Associations between the mortality risk and the surgical correction of VI (visual acuity [VA] <20/40, attributable to cataract) were assessed in Cox proportional hazard regression models, after multivariate adjustment, using time-dependent variables for the study factor.

MAIN OUTCOME MEASURES

All-cause mortality.

RESULTS

The 15-year crude mortality of participants who had undergone cataract surgery at baseline with no subsequent VI (71.8%) was relatively similar to that in participants with cataract-related VI who had not yet undergone surgery (79.4%). However, after adjusting for age and sex, participants who underwent cataract surgery before baseline or during follow-up and no longer had VI had significantly lower long-term mortality risk (hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.46-0.77) than participants with VI due to cataract who had not undergone cataract surgery. This lower mortality risk in the group with surgically corrected VI (HR, 0.54; 95% CI, 0.41-0.73) persisted after further adjustment for smoking, body mass index, home ownership, qualifications, poor self-rated health, the presence of poor mobility, hypertension, diabetes, self-reported history of angina, myocardial infarction, stroke, cancer, asthma, and arthritis. This finding remained significant (HR, 0.55; 95% CI, 0.41-0.73) after additional adjustment for the number of medications taken (continuous variable) and the number (≥ 5 vs. <5) of comorbid conditions (poor mobility, hypertension, diabetes, angina, myocardial infarction, stroke, cancer, asthma, or arthritis) as indicators of frailty.

CONCLUSIONS

Surgical correction of VI due to cataract was associated with significantly better long-term survival of older persons after accounting for known cataract and mortality risk factors, and indicators of general health. Whether some uncontrolled factors (frailty or general health) could have influenced decisions not to perform cataract surgery in some participants is unknown. However, this finding strongly supports many previous reports linking VI with poor survival.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

摘要

目的

评估在澳大利亚老年人群中,白内障手术矫正视力损害(VI)是否与长期生存改善相关。

设计

基于人群的队列研究。

参与者

在蓝山眼病研究中,354 名年龄≥49 岁的参与者患有白内障和 VI,或在基线检查前已接受白内障手术。随后在 5 年和 10 年随访后进行检查。

方法

使用时间依赖性变量评估 Cox 比例风险回归模型中,视力(VA)<20/40 与手术矫正 VI(归因于白内障)之间的死亡率风险之间的关联,该模型进行了多变量调整。

主要观察指标

全因死亡率。

结果

基线时已接受白内障手术且随后未出现 VI 的参与者的 15 年粗死亡率(71.8%)与尚未接受白内障手术但患有白内障相关 VI 的参与者(79.4%)相似。然而,在校正年龄和性别后,基线前或随访期间接受白内障手术且不再有 VI 的参与者的长期死亡率风险显著降低(风险比[HR],0.60;95%置信区间[CI],0.46-0.77),与未接受白内障手术的白内障相关 VI 参与者相比。在进一步调整吸烟、体重指数、住房所有权、资格、自我报告健康状况差、活动能力差、高血压、糖尿病、自述心绞痛、心肌梗死、中风、癌症、哮喘和关节炎等因素后,手术矫正 VI(HR,0.54;95% CI,0.41-0.73)的这种较低死亡率风险仍然显著。在进一步调整所服用药物数量(连续变量)和合并症数量(≥5 项与<5 项[活动能力差、高血压、糖尿病、心绞痛、心肌梗死、中风、癌症、哮喘或关节炎]作为脆弱性指标)后,这一发现仍然具有统计学意义(HR,0.55;95% CI,0.41-0.73)。

结论

在考虑已知的白内障和死亡率风险因素以及一般健康指标后,白内障引起的 VI 的手术矫正与老年人的长期生存显著改善相关。一些不可控因素(脆弱性或整体健康)是否会影响一些参与者不进行白内障手术的决定尚不清楚。然而,这一发现强烈支持了许多之前将 VI 与较差的生存联系起来的报告。

利益披露

参考文献之后可能会发现专有或商业披露。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验